Profit margins, US medicine supplies may get hit: Biocon

BENGALURU: Biocon is gearing up to manage potential challenges arising from US govt’s proposed tariffs on pharma imports. The company cautioned that these higher duties could impact profit margins and disrupt the availability of affordable generic medicines for American patients.The US remains Biocon’s largest market, contributing a significant share of its overall sales. However, the…

Read More

Nvidia gets green light: US clears chip exports to China; company avoids billion dollars hit after CEO’s meeting with Trump

The United States Commerce Department has begun issuing licenses to Nvidia to export its H20 chips to China, a US official told Reuters on Friday, marking a major breakthrough for the AI giant’s access to one of its most important markets.The move follows Washington’s decision last month to reverse an April ban on sales of…

Read More